Synthetic Biotechnology is an innovative field that combines principles of biology and engineering to design and construct new biological entities or redesign existing ones for specific purposes. It involves the application of engineering principles to create synthetic biological systems with enhanced functionalities.
Researchers in Synthetic Biotechnology use genetic engineering, molecular biology, and computational methods to construct artificial biological components, such as genes and proteins, and assemble them into functional systems. These metabolic engineering systems can be used for a range of applications, including the production of biofuels, pharmaceuticals, and biomaterials. This field aims to create biological systems with novel properties that go beyond what is found in nature. Ethical considerations and safety precautions are paramount in Synthetic Biotechnology, as it involves the intentional modification of living organisms. Ongoing advancements in this field hold promise for addressing challenges in medicine, energy production. Successful translation relies on collaborative efforts between scientists, clinicians, and industry professionals, accelerating the transformation of research discoveries into tangible benefits for patients.
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Precision diagnostics: Effectiveness of innovative imaging technologies for early detection of lung cancers
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Design and characterization of gum arabic buccal films for protein drug delivery
Krisztian Pamlenyi, University of Szeged, Hungary